Home / DLL1 Knockout Cell Lines

DLL1 Knockout Cell Lines

Gene: DLL1

Official Full Name: delta like canonical Notch ligand 1provided by HGNC

Gene Summary: DLL1 is a human homolog of the Notch Delta ligand and is a member of the delta/serrate/jagged family. It plays a role in mediating cell fate decisions during hematopoiesis. It may play a role in cell-to-cell communication. [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO11431 DLL1 Knockout cell line (HCT 116) Human DLL1 1:2~1:4 Negative Online Inquiry

Background

DLL1 Gene Knockout Cell Lines are genetically engineered cell lines in which the DLL1 gene has been specifically disrupted or inactivated through advanced gene editing techniques such as CRISPR/Cas9. These cell lines provide invaluable tools for researchers studying the Notch signaling pathway, as DLL1 is a crucial ligand in this pathway involved in various cellular processes including differentiation, proliferation, and apoptosis. By simulating the loss of DLL1 function, these knockout cell lines allow for in-depth analysis of the gene's roles in cellular communication and development, as well as its implications in diseases such as cancer and developmental disorders.

The primary mechanism of action in these knockout cell lines lies in the elimination of DLL1 expression, which leads to a significant alteration in Notch signaling dynamics. Consequently, researchers can investigate the phenotypic changes and downstream molecular effects triggered by the absence of DLL1, allowing for a clearer understanding of the gene's involvement in specific biological pathways. This capability enables scientists to dissect complex signaling networks and explore potential therapeutic targets.

The scientific significance of DLL1 Gene Knockout Cell Lines extends far beyond basic research; they are instrumental in translational studies focusing on cancer therapy, regenerative medicine, and cell fate determination. By illuminating the mechanisms underpinning Notch signaling abnormalities, researchers can develop novel treatment strategies tailored to diseases driven by these pathways.

What sets DLL1 Gene Knockout Cell Lines apart from alternative cell models is their precise genetic modification, which ensures a consistent and reproducible research environment. Unlike traditional knockdown approaches, which may produce variable results due to incomplete inhibition, these knockout models present a definitive absence of the DLL1 gene, ensuring robust experimental outcomes.

For researchers and clinicians, the value of utilizing DLL1 Gene Knockout Cell Lines lies in their ability to provide comprehensive insights into Notch-associated pathologies and therapeutic strategies. By leveraging these advanced models, users can enhance their understanding of fundamental biological processes and translate their findings into conditions relevant to human health.

Our company specializes in the development and characterization of innovative biological products, ensuring that our customers receive high-quality, reliable tools that facilitate groundbreaking research. With extensive expertise in gene editing technologies and a commitment to scientific excellence, we empower researchers to make meaningful discoveries in their respective fields.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.